Prothena Corporation PLC at Barclays Global Healthcare Conference Transcript
Okay. Today we're lucky enough to have Prothena with us. We have Gene Kinney, CEO; and Tran Nguyen, CFO. My name is Greg Harrison. I'm an associate on Geoff Meacham's team, and with me is Scott Puckhaber.
Questions & Answers
So I guess we'll just get right into it, maybe start off with the prasinezumab program in Parkinson's. So you recently published the Phase 1b data. Just curious, we saw a good PK/PD profile. What, beyond that, did you guys find especially meaningful as you progressed this program?
Yes, I know. Well, first, Greg and Scott, thank you for having us. We very much appreciate being here. Yes, just to speak a little bit about prasinezumab. Maybe I can kind of introduce a little bit of science behind it, then we can talk about this Phase 1b results. So that's a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
